Cetera Advisors LLC Evolus, Inc. Transaction History

Cetera Advisors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$7.15 - $10.2 $1,322 - $1,886	185 Added 1.64%	11,477 $104,000
Q2 2023 Aug 09, 2023	BUY	$7.23 - $10.52 $3,542 - $5,154	490 Added 4.54%	11,292 $82,000
Q1 2023 May 15, 2023	SELL	$7.81 - $11.05 $132,504 - $187,474	-16,966 Reduced 61.1%	10,802 $91,000
Q4 2022 Feb 14, 2023	BUY	$6.52 - $8.95 $181,047 - $248,523	27,768 New	27,768 $208,000
Q2 2022 Aug 11, 2022	SELL	$10.22 - $13.94 $253,404 - $345,642	-24,795 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$5.22 - $11.78 $129,429 - $292,085	24,795 New	24,795 $278,000

168

47.8M

130K

51K

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $608M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisors LLC with notifications on news.